This is a preview of subscription content, log in via an institution to check access.
Notes
2013 British pounds
Reference
Lee TY, et al. Cost-effectiveness of long-acting insulin analogues versus intermediate/long-acting human insulin for type 1 diabetes: a population-based cohort following over 10 years. British Journal of Clinical Pharmacology : 29 Nov 2019. Available from: URL: http://doi.org/10.1111/bcp.14188
Rights and permissions
About this article
Cite this article
Long-acting insulin analogues cost effective for type 1 diabetes. PharmacoEcon Outcomes News 843, 24 (2019). https://doi.org/10.1007/s40274-019-6451-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6451-z